Immucor, Inc. - Medical Equipment - Deals and Alliances Profile

Date: November 14, 2016
Pages: 28
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: IF276A39BFAEN
Leaflet:

Download PDF Leaflet

Immucor, Inc. - Medical Equipment - Deals and Alliances Profile
Summary

Immucor, Inc. (Immucor) is an in-vitro diagnostics company, which specializes in the area of pre-transfusion diagnostics. It carries out the development, production and sale of a comprehensive line of reagents and automated systems. The company’s products are used in performing the tests to detect and identify certain properties of the cell and serum components of human blood before the process of blood transfusion. Its major customers include hospitals, clinical laboratories and blood banks. Immucor offers its solutions to blood banks, transfusion laboratories and small- and medium-sized hospitals. The company has operations in Germany, Italy, Portugal, Canada, Spain, Belgium, France, India, Japan, the UK and the US; and it has manufacturing facilities in US and Canada. Immucor is headquartered in Norcross, Georgia, the US.

Immucor, Inc. - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.
Immucor, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Immucor, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016
Immucor, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Immucor, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016
Immucor, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
Immucor, Inc., Medical Equipment, Deal Details
Asset Purchase
Immucor Completes Acquisition Of Lifecodes Business Of Hologic For US$95 Million
Private Equity
TPG Capital Completes Acquisition Of Immucor For US$1.94 Billion
Partnerships
Immucor Enters into Co-Marketing Agreement with Sirona Genomics
BioCSL Enters into Distribution Agreement with Immucor for Capture
Acquisition
Immucor Acquires Sentilus
Immucor Acquires Organ-i, Molecular Diagnostic Company
Immucor, Inc. - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Corporate Communications
Jun 29, 2015: Jeffrey R. Binder Appointed President and CEO of Immucor
Product News
Mar 21, 2016: Immucor’s ImmuLINK Software Suite v1.7 Receives FDA Clearance to Interface with PreciseType HEA
Feb 03, 2016: Immucor and Sirona Genomics Announce CE Mark for MIA FORA NGS HLA Typing Solution
Product Approvals
Mar 21, 2016: Immucor’s ImmuLINK Software Suite v1.7 Receives FDA Clearance to Interface with PreciseType HEA
Feb 03, 2016: Immucor and Sirona Genomics Announce CE Mark for MIA FORA NGS HLA Typing Solution
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Immucor, Inc., Medical Equipment, Key Facts, 2016
Immucor, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
Immucor, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Immucor, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016
Immucor, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Immucor, Inc., Deals By Market, 2010 to YTD 2016
Immucor, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
Immucor Completes Acquisition Of Lifecodes Business Of Hologic For US$95 Million
TPG Capital Completes Acquisition Of Immucor For US$1.94 Billion
Immucor Enters into Co-Marketing Agreement with Sirona Genomics
BioCSL Enters into Distribution Agreement with Immucor for Capture
Immucor Acquires Sentilus
Immucor Acquires Organ-i, Molecular Diagnostic Company
Immucor, Inc., Key Competitors
Immucor, Inc., Key Employees
Immucor, Inc., Other Locations
Immucor, Inc., Subsidiaries

LIST OF FIGURES

Immucor, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016
Immucor, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Immucor, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Immucor, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016
Immucor, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Immucor, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016
Immucor, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Immucor, Inc., Medical Equipment, Deals by Market, 2010 to YTD 2016
Skip to top


Ask Your Question

Immucor, Inc. - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: